Nasdaq · CIK 0001611842
PYPD PolyPid Ltd.
Insider trading from SEC Form 4. Last filing Jul 17, 2026.
In brief
PolyPid Ltd. (PYPD) has 10 SEC Form 4 filings on file from 10 insiders, the latest filed on Jul 17, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at PolyPid Ltd., scored.
Transactions
Every row filed, 10 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Dikla Czaczkes Akselbrad Chief Executive Officer | AGrant or award Stock option (right to buy)derivative | +149,000 | $4.46 | $665k | 149,000 | Jul 17, 2026 |
| Jul 15, 2026 | Yechezkel Barenholz director | AGrant or award Stock option (right to buy)derivative | +9,132 | $4.46 | $41k | 9,132 | Jul 17, 2026 |
| Jul 15, 2026 | Joseph BenAmram director | AGrant or award Stock option (right to buy)derivative | +9,132 | $4.46 | $41k | 9,132 | Jul 17, 2026 |
| Jul 15, 2026 | Nir Dror-Darwish director | AGrant or award Stock option (right to buy)derivative | +9,132 | $4.46 | $41k | 9,132 | Jul 17, 2026 |
| Jul 15, 2026 | Itzhak Krinsky director | AGrant or award Stock option (right to buy)derivative | +9,132 | $4.46 | $41k | 9,132 | Jul 17, 2026 |
| Jul 15, 2026 | Brooke Story director | AGrant or award Stock option (right to buy)derivative | +9,132 | $4.46 | $41k | 9,132 | Jul 17, 2026 |
| Jul 15, 2026 | Robert Benjamin Stein director | AGrant or award Stock option (right to buy)derivative | +9,132 | $4.46 | $41k | 9,132 | Jul 17, 2026 |
| May 11, 2026 | Dalit Fellous Hazan Deputy CEO, EVP, RD, CRA | AGrant or award Stock option (right to buy)derivative | +75,000 | $4.46 | $335k | 75,000 | Jul 17, 2026 |
| May 11, 2026 | Jonathan Missulawin Chief Financial Officer | AGrant or award Stock option (right to buy)derivative | +49,000 | $4.46 | $219k | 49,000 | Jul 17, 2026 |
| May 11, 2026 | Ori Warshavsky Chief Operating Officer - US | AGrant or award Stock option (right to buy)derivative | +46,000 | $4.46 | $205k | 46,000 | Jul 17, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Dikla Czaczkes AkselbradChief Executive Officer
- Yechezkel Barenholzdirector
- Joseph BenAmramdirector
- Nir Dror-Darwishdirector
- Dalit Fellous HazanDeputy CEO, EVP, RD, CRA
- Itzhak Krinskydirector
- Jonathan MissulawinChief Financial Officer
- Robert Benjamin Steindirector
- Brooke Storydirector
- Ori WarshavskyChief Operating Officer - US
Questions about PYPD
Answered from the filings on this page, as of the latest one.
Are insiders buying PYPD?
No. In the last 90 days no insider at PolyPid Ltd. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PYPD on the open market?
No open-market trade has been scored at PolyPid Ltd.. The latest Form 4 on file was filed on Jul 17, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at PolyPid Ltd.?
10 people have filed a Form 4 at PolyPid Ltd., among them Dikla Czaczkes Akselbrad (Chief Executive Officer), Yechezkel Barenholz (director), Joseph BenAmram (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.